Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127,665 | 135,551 | 66,329 | 77,617 | 76,190 |
| Marketable Securities | 255,669 | 232,670 | 365,343 | 145,918 | 364,506 |
| Receivables | 53,976 | 41,123 | 31,057 | 27,625 | 26,198 |
| Inventories | 12,412 | 7,730 | 6,100 | 4,988 | 4,910 |
| Other current assets | 0 | 14,000 | 14,000 | 0 | 0 |
| TOTAL | $471,602 | $458,636 | $499,253 | $266,463 | $478,501 |
| Non-Current Assets | |||||
| PPE Net | 2,689 | 195 | 633 | 1,002 | 1,675 |
| Investments And Advances | 219,831 | 57,176 | 4,947 | 112,277 | 36,196 |
| Other Non-Current Assets | 146,431 | 105,510 | 78,597 | 44,014 | 55,359 |
| TOTAL | $368,951 | $162,881 | $84,177 | $157,293 | $93,230 |
| Total Assets | $840,553 | $621,517 | $583,430 | $423,756 | $571,731 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,376 | 17,396 | 11,976 | 6,908 | 10,554 |
| Accrued Expenses | 124,568 | 72,958 | 28,573 | 40,107 | 13,704 |
| Other current liabilities | N/A | 14,000 | N/A | N/A | N/A |
| TOTAL | $140,773 | $104,505 | $72,491 | $47,541 | $47,494 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,107 | 0 | 0 | 0 | 501 |
| TOTAL | $20,191 | $10,307 | $9,097 | $409 | $899 |
| Total Liabilities | $160,964 | $114,812 | $81,588 | $47,950 | $48,393 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,503 | 103,517 | 107,899 | 105,962 | 117,312 |
| Common Shares | 136 | 133 | 131 | 127 | 122 |
| Retained earnings | 543,735 | 402,526 | 296,386 | 194,968 | 82,456 |
| Other shareholders' equity | -390 | 531 | -1,017 | -638 | 620 |
| TOTAL | $679,589 | $506,705 | $501,842 | $375,806 | $523,338 |
| Total Liabilities And Equity | $840,553 | $621,517 | $583,430 | $423,756 | $571,731 |